Skip to main content

Table 1 Clinical characteristics of patients with nosocomial pneumonia caused by different Pseudomonas aerugionsa serotypes (n = 123)

From: Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes

Serotypes

All

O1

O2

O6

O10

O11

PL5

NT

VAP/NP, n (%)

114/123 (93)

9/10 (90)

10/11 (91)

35/36 (92)

10/12 (83)

26/28 (93)

15/16 (94)

9/10 (90)

Age, years

61 (43 to 72)

65 (56 to 74)

63 (58 to 70)

57 (39 to 67)

59 (40 to 77)

65 (42 to 78)

64 (47 to 71)

64 (59 to 72)

Male%

75

40

73

81

92

68

81

80

Antibiotics at pneumonia onset, n, %

84 (68)

5 (50)

8 (73)

28 (78)

12 (100)

13 (46)

12 (75)

6 (60)

Inappropriately treated %

11

0

0

14

8

14

6

0

MCPIS

7.0 (5.0 to 9.0)

8.0 (5.8 to 9.5)

9.0 7 to 10)

7 (5 to 8)

6 (4 to 8)

8.5 (7 to 9.5)

7.5 5 to 9)

6.0 (4 to 8)

APACHE II score

17 (12 to 22)

17 (11 to 29)

15 (11 to 17)

17 (11to 23)

17 (11 to 29)

17 (14 to 20)

19 (12 to 26)

16 (12 to 19)

SOFA score

7.0 (5.0 to10.0)

9.5 (6.5 to 15.0)

5 (4 to 7)

7 (5 to 10)

9.5 (6.5 to 15.0)

6.0 (4.5 to 8.0)

7 (6.0 to 9.0)

6.0 (4.0 to 9.2)

Hospital length of stay at inclusion, days

13 (7 to 14)

14 (8 to 45)

8 (4 to 18)

12 (7 to 25)

13 (8 to 19)

18 (8 to 34)

12 (6 to 24)

14 (8 to 25)

ICU length of stay at inclusion, days

8 (4 to 17)

11 (4 to 17)

5 (3 to 12)

7 (5 to 19)

8 (3 to 13)

9 (6 to 19)

8 (4 to 15)

9 (5 to 14)

Duration of mechanical ventilation at inclusion, days

8 (5 to 17)

10.5 (7 to 17)

5 (3 to 12)

8 (5 to18)

9 (4 to 13)

9 (5 to 17)

8 (4 to 15)

9 (6 to 14)

  1. Data are expressed as median and 25%-75% interquartile. Nosocomial pneumonia (NP) includes hospital-acquired pneumonia and ventilator-associated pneumonia (VAP). APACHE II, Acute Physiology and Chronic Health Evaluation II; ICU, intensive care unit; MCPIS, modified clinical pulmonary infection score; NT, not typeable; PL5, sum of all serotypes with a prevalence of less than 5%; SOFA, sequential organ failure assessment.